PMC:7402624 / 24780-25001 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T196","span":{"begin":13,"end":18},"obj":"Body_part"},{"id":"T197","span":{"begin":91,"end":97},"obj":"Body_part"}],"attributes":[{"id":"A196","pred":"fma_id","subj":"T196","obj":"http://purl.org/sig/ont/fma/fma9670"},{"id":"A197","pred":"fma_id","subj":"T197","obj":"http://purl.org/sig/ont/fma/fma62970"}],"text":"ative in the blood by PCR could be studied (fig. S4A). Half of these COVID-19 patients had plasma CXCL10 concentrations that were ~15 fold higher than HD controls, whereas the remainder showed only a limited increase (fig"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T12","span":{"begin":13,"end":18},"obj":"Body_part"}],"attributes":[{"id":"A12","pred":"uberon_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"}],"text":"ative in the blood by PCR could be studied (fig. S4A). Half of these COVID-19 patients had plasma CXCL10 concentrations that were ~15 fold higher than HD controls, whereas the remainder showed only a limited increase (fig"}

{"project":"LitCovid-PubTator","denotations":[{"id":"914","span":{"begin":98,"end":104},"obj":"Gene"},{"id":"937","span":{"begin":78,"end":86},"obj":"Species"},{"id":"950","span":{"begin":69,"end":77},"obj":"Disease"},{"id":"951","span":{"begin":151,"end":153},"obj":"Disease"}],"attributes":[{"id":"A914","pred":"tao:has_database_id","subj":"914","obj":"Gene:3627"},{"id":"A937","pred":"tao:has_database_id","subj":"937","obj":"Tax:9606"},{"id":"A950","pred":"tao:has_database_id","subj":"950","obj":"MESH:C000657245"},{"id":"A951","pred":"tao:has_database_id","subj":"951","obj":"MESH:D006816"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ative in the blood by PCR could be studied (fig. S4A). Half of these COVID-19 patients had plasma CXCL10 concentrations that were ~15 fold higher than HD controls, whereas the remainder showed only a limited increase (fig"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T181","span":{"begin":69,"end":77},"obj":"Disease"},{"id":"T182","span":{"begin":151,"end":153},"obj":"Disease"}],"attributes":[{"id":"A181","pred":"mondo_id","subj":"T181","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A182","pred":"mondo_id","subj":"T182","obj":"http://purl.obolibrary.org/obo/MONDO_0007739"}],"text":"ative in the blood by PCR could be studied (fig. S4A). Half of these COVID-19 patients had plasma CXCL10 concentrations that were ~15 fold higher than HD controls, whereas the remainder showed only a limited increase (fig"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T446","span":{"begin":13,"end":18},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"T447","span":{"begin":13,"end":18},"obj":"http://www.ebi.ac.uk/efo/EFO_0000296"},{"id":"T448","span":{"begin":91,"end":97},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"},{"id":"T449","span":{"begin":198,"end":199},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"ative in the blood by PCR could be studied (fig. S4A). Half of these COVID-19 patients had plasma CXCL10 concentrations that were ~15 fold higher than HD controls, whereas the remainder showed only a limited increase (fig"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T145","span":{"begin":98,"end":104},"obj":"Chemical"},{"id":"T146","span":{"begin":151,"end":153},"obj":"Chemical"}],"attributes":[{"id":"A145","pred":"chebi_id","subj":"T145","obj":"http://purl.obolibrary.org/obo/CHEBI_138157"},{"id":"A146","pred":"chebi_id","subj":"T146","obj":"http://purl.obolibrary.org/obo/CHEBI_73925"}],"text":"ative in the blood by PCR could be studied (fig. S4A). Half of these COVID-19 patients had plasma CXCL10 concentrations that were ~15 fold higher than HD controls, whereas the remainder showed only a limited increase (fig"}